JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

A

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

A

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

A

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

A

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

A

133.74

+0.46%↑

Search

Microbot Medical Inc

Uždarymo kaina

1.8 -1.64

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.79

Max

1.88

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-77K

-3.6M

Darbuotojai

20

EBITDA

-79K

-3.6M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+360.53% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-03-23

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-11M

129M

Ankstesnė atidarymo kaina

3.44

Ankstesnė uždarymo kaina

1.8

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-30 20:14; UTC

Įsigijimai, susijungimai, perėmimai

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

2026-01-30 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

2026-01-30 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

2026-01-30 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

2026-01-30 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

2026-01-30 23:47; UTC

Įsigijimai, susijungimai, perėmimai

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

2026-01-30 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

2026-01-30 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

2026-01-30 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

2026-01-30 23:41; UTC

Rinkos pokalbiai

Deckers Outdoor Seen as Undervalued -- Market Talk

2026-01-30 23:12; UTC

Įsigijimai, susijungimai, perėmimai

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

2026-01-30 22:20; UTC

Uždarbis

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

2026-01-30 22:10; UTC

Rinkos pokalbiai

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

2026-01-30 21:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2026-01-30 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-30 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-01-30 21:42; UTC

Uždarbis

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

2026-01-30 21:36; UTC

Uždarbis

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

2026-01-30 21:33; UTC

Uždarbis

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

2026-01-30 20:42; UTC

Uždarbis

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

2026-01-30 20:37; UTC

Įsigijimai, susijungimai, perėmimai

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

2026-01-30 20:20; UTC

Rinkos pokalbiai

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

2026-01-30 20:13; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

2026-01-30 19:52; UTC

Uždarbis

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

2026-01-30 19:29; UTC

Rinkos pokalbiai
Uždarbis

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

2026-01-30 19:09; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-30 19:09; UTC

Rinkos pokalbiai

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

2026-01-30 19:07; UTC

Rinkos pokalbiai

Canada Performing Well Below Economic Potential -- Market Talk

2026-01-30 18:46; UTC

Uždarbis

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

2026-01-30 18:34; UTC

Uždarbis

Exxon, Chevron Post Slimmest Annual Profits Since 2021 -- 2nd Update

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

360.53% į viršų

12 mėnesių prognozė

Vidutinis 8.75 USD  360.53%

Aukščiausias 12 USD

Žemiausias 5.5 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat